In this study, we demonstrate a critical prosurvival role for the IGF-1/MEK1signaling axis in breast cancer cells undergoing antiestrogen and antiprogestin treatment and uniquely demonstrate that the underlying mechanism of MEK1-mediated survival is via blockade of the proapoptotic action of the BH3-only protein BimEL. This evidence concerns the gene MAP2K1 and breast cancer.